To further elucidate the effect of HJD on JAK2/STAT3 pathway, AG490, a specific JAK2 inhibitor, was used to block the JAK2/STAT3 pathway [24]. Here, JAK2 is linked to spondyloepimetaphyseal dysplasia, Handigodu type.